ストックスクリーナーアプリを入手
0.339
0.88%
-0.003
プレマーケット:
.34
0.001
+0.29%
前日終値:
$0.342
開ける：
$0.334
24時間の取引高:
1.10M
Relative Volume:
0.18
時価総額：
$5.79M
収益：
$743.00K
当期純損益:
$-7.63M
株価収益率:
-0.113
EPS:
-3
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.89%
1か月 パフォーマンス:
-17.32%
6か月 パフォーマンス:
-69.46%
1年 パフォーマンス:
-78.68%
1日の値動き範囲:
$0.3301
$0.3484
1週間の範囲:
$0.3301
$0.3948
52週間の値動き範囲:
$0.28
$2.33
Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile
名前
Can-Fite Biopharma Ltd ADR
セクター
電話
972 3 924 1114
住所
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
CANF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
0.339 | 5.84M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2017-08-11 | 開始されました | Maxim Group | Buy |
| 2016-10-19 | 再開されました | ROTH Capital | Buy |
| 2016-08-29 | 再開されました | Rodman & Renshaw | Buy |
| 2015-11-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-03-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-03-30 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2014-12-29 | 繰り返されました | ROTH Capital | Buy |
| 2014-11-18 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Can-Fite Biopharma Ltd ADR (CANF) 最新ニュース
Can Can Fite Biopharma Ltd Sponsored ADR stock sustain breakout momentum2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock test all time highsMarket Performance Report & Free Expert Approved Momentum Trade Ideas - Newser
How big funds are accumulating Can Fite Biopharma Ltd Sponsored ADR stockDividend Hike & AI Enhanced Trade Execution Alerts - Newser
Is Can Fite Biopharma Ltd Sponsored ADR stock positioned for secular growth2025 Key Lessons & Growth Focused Entry Reports - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock deliver double digit returnsJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock survive global slowdown2025 Analyst Calls & Safe Entry Point Identification - Newser
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference - sahmcapital.com
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
You might want to take a look at Pasithea Therapeutics Corp (KTTA) now - Setenews
Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil - sahmcapital.com
Will Can Fite Biopharma Ltd Sponsored ADR stock beat revenue estimatesQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong analyst pickJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Can Can Fite Biopharma Ltd Sponsored ADR stock expand revenue streams - newser.com
Take off with Santech Holdings Ltd. ADR (STEC): Get ready for trading - Setenews
How does Can-Fite Biopharma Ltd ADR (CANF) change from a tortoise to a hare? - Setenews
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson - sahmcapital.com
Will Can Fite Biopharma Ltd Sponsored ADR stock see insider accumulationJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Can-Fite Biopharma Ltd ADR (CANF) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):